{
    "organizations": [],
    "uuid": "0cff93fd6b22f02b2b336d133787eb71ddb64a59",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amerisourcebergen-reports-fiscal-2/brief-amerisourcebergen-reports-fiscal-2018-first-quarter-results-idUSASB0C456",
    "ord_in_thread": 0,
    "title": "BRIEF-Amerisourcebergen Reports Fiscal 2018 First Quarter Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 43 AM / in 5 minutes BRIEF-Amerisourcebergen Reports Fiscal 2018 First Quarter Results Reuters Staff \nFeb 6 (Reuters) - Amerisourcebergen Corp: \n* AMERISOURCEBERGEN REPORTS FISCAL 2018 FIRST QUARTER RESULTS * SEES FY 2018 ADJUSTED EARNINGS PER SHARE $6.45 TO $6.65 \n* Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.55 EXCLUDING ITEMS * Q1 GAAP EARNINGS PER SHARE $3.90 \n* REVENUES OF $40.5 BILLION FOR Q1, A 6.0 PERCENT INCREASE YEAR-OVER-YEAR \n* AMERISOURCEBERGEN - ADJUSTED EARNINGS PER SHARE BENEFIT FROM U.S. TAX REFORM IS EXPECTED TO BE ABOUT $0.60 IN FISCAL 2018 \n* SEES 2018 ‍ADJUSTED DILUTED EARNINGS PER SHARE TO BE IN RANGE OF $6.45 TO $6.65​ \n* SEES 2018 ‍REVENUE GROWTH IN RANGE OF 8 PERCENT TO 11 PERCENT​ \n* AMERISOURCEBERGEN - “REMAIN CONFIDENT IN PHARMEDIUM‘S ABILITY TO RETURN TO ITS LONG-TERM GROWTH TRAJECTORY” \n* SEES 2018 ‍CAPITAL EXPENDITURES OF APPROXIMATELY $325 MILLION​ \n* Q1 EARNINGS PER SHARE VIEW $1.35, REVENUE VIEW $40.50 BILLION -- THOMSON REUTERS I/B/E/S \n* FY2018 EARNINGS PER SHARE VIEW $6.29, REVENUE VIEW $166.80 BILLION -- THOMSON REUTERS I/B/E/S \n* AMERISOURCEBERGEN - CONTINUES TO OPERATE UNDER ASSUMPTION THAT BRAND DRUG INFLATION WILL BE IN RANGE OF 6 PERCENT TO 7 PERCENT FOR PHARMACEUTICAL MARKET IN 2018 \n* AMERISOURCEBERGEN - CONTINUES TO OPERATE UNDER ASSUMPTION THAT GENERIC DRUG DEFLATION WILL BE IN RANGE OF -7 PERCENT TO -9 PERCENT FOR PHARMACEUTICAL MARKET IN 2018 Source text for Eikon:  ",
    "published": "2018-02-06T13:41:00.000+02:00",
    "crawled": "2018-02-06T13:53:47.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "report",
        "fiscal",
        "first",
        "quarter",
        "result",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "amerisourcebergen",
        "corp",
        "amerisourcebergen",
        "report",
        "fiscal",
        "first",
        "quarter",
        "result",
        "see",
        "fy",
        "adjusted",
        "earnings",
        "per",
        "share",
        "q1",
        "adjusted",
        "earnings",
        "per",
        "share",
        "excluding",
        "item",
        "q1",
        "gaap",
        "earnings",
        "per",
        "share",
        "revenue",
        "billion",
        "q1",
        "percent",
        "increase",
        "amerisourcebergen",
        "adjusted",
        "earnings",
        "per",
        "share",
        "benefit",
        "tax",
        "reform",
        "expected",
        "fiscal",
        "see",
        "diluted",
        "earnings",
        "per",
        "share",
        "range",
        "see",
        "growth",
        "range",
        "percent",
        "amerisourcebergen",
        "remain",
        "confident",
        "pharmedium",
        "ability",
        "return",
        "growth",
        "trajectory",
        "see",
        "expenditure",
        "approximately",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "amerisourcebergen",
        "continues",
        "operate",
        "assumption",
        "brand",
        "drug",
        "inflation",
        "range",
        "percent",
        "percent",
        "pharmaceutical",
        "market",
        "amerisourcebergen",
        "continues",
        "operate",
        "assumption",
        "generic",
        "drug",
        "deflation",
        "range",
        "percent",
        "percent",
        "pharmaceutical",
        "market",
        "source",
        "text",
        "eikon"
    ]
}